[EN] SUBSTITUTED HYDROXYETHYLAMINE ASPARTYL PROTEASE INHIBITORS<br/>[FR] ASPARTYLE A BASE D'HYDROXYETHYLAMINE SUBSTITUE INHIBITEURS DE LA PROTEASE
申请人:ELAN PHARM INC
公开号:WO2005087751A2
公开(公告)日:2005-09-22
The invention relates to novel compounds and also to methods of treating at least one disease, disorder, or condition associated with amyloidosis using such compounds. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.